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Background: Both obesity and type II diabetes mellitus are associated with insulin resistance and abnormal
metabolic reactions. This study was conducted to evaluate resting metabolic rate in obese diabetic patients and to
assess its relation to glycaemic control.
Results: This is a case control study conducted in Gabir AbuEliz centre in Khartoum, Sudan. A random sample
of 40 obese diabetic patients (cases) and 40 obese non-diabetic subjects (controls) were interviewed and examined
clinically to exclude presence of acute or chronic medical illness. Haemoglobin A1c was measured for each
participant using the “NycoCard Haemoglobin A1c test” (Axis -Shield/ Norway). Fasting blood sugar was measured
using one touch(R) glucometer (LifeScan Canada Ltd). The PowerLab 8/35 with a gas analyzer (AD Instruments,
Castle Hill Australia) was used for measurement of VO2, VCO2 and Respiratory exchange ratio (RER). Resting
metabolic rate was calculated using the Weir equation. VO2 (mean+/−SD) ml/min was significantly higher among
cases (209.9+/−42.7) compared to the controls (192.4+/−28.1), (P = 0.034). Similarly, VCO2 (mean+/−SD) ml/min was
higher among cases (191.4+/−35.0) than controls (178.3+/−22.5), (P = 0.05). Resting metabolic rate “RMR”
(mean+/−SD) kcal/day was higher in obese diabetic patients (1480.7 +/− 274.2) than obese non-diabetic subjects
(1362.4+/− 184.8), (P = 0.027). Participants with high glycated haemoglobin had higher RMR than those with normal
glycated haemoglobin (P = 0.016).
Conclusion: It is concluded that resting metabolic rate is significantly higher in obese diabetic patients compared
to obese non-diabetics, especially in those with poor glycaemic control.
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metabolic rateBackground
Measurement of resting energy expenditure is essential
for nutritional assessment, weight loss planning and
optimum medical care. Indirect calorimetry is the pri-
mary method for metabolic rate measurement. It in-
volves measurement of oxygen consumption (VO2) and
carbon dioxide production (VCO2) for calculation of
caloric burning rate. The relation between these gases
and metabolic rate is defined by the Weir equation
which is widely used for metabolic rate calculations
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sistance and type 2 diabetes mellitus. Insulin resistance
in obese diabetic individuals is associated with abnormal
metabolic reactions in skeletal muscle, liver and adipose
tissue. Management and prevention of long term com-
plications in diabetic patients depend on tight glycaemic
control. Laboratory indicators of glycaemic control in a
diabetic patient are haemoglobin A1c (Hb A1c) and
fasting blood sugar (FBS). The quantity of Hb A1c
within a red blood cell reflects the average level of
glucose to which the cell has been exposed during its
life-cycle. Measuring Hb A1c assesses the level of gly-
caemic control over the previous four weeks to three
months. Normal value is about 5% of total haemoglobin
in adults. It was recommended that a threshold of ≥6.5%Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of cases and controls in the study
group
Parameter Study group Min Max Mean SD P value
Age (y) Cases 35 50 45.03 5.09 0.564
Controls 35 50 44.33 5.69
Height (m) Cases 1.49 1.81 1.63 0.08 0.094
Controls 1.55 1.83 1.66 0.08
Weight (kg) Cases 69 105 85.00 7.70 0.486
Controls 78 105 86.52 11.35
BMI (kg/m2) Cases 30.02 40.37 32.04 2.08 0.328
Controls 30.04 39.85 32.29 2.06
Surface area (m2) Cases 1.69 2.30 1.96 0.128 0.078
Controls 1.85 2.31 2.01 0.126
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studies reported higher resting metabolic rate among
diabetic patients compared to the non-diabetics. Weyer
and his colleagues in 1999 found progressive increase in
resting metabolic rate in patients in whom their glucose
tolerance deteriorated from normal glucose tolerance to
impaired glucose tolerance to diabetes [4]. They attri-
buted the rise in resting metabolic rate to metabolic
changes that occur during early stages of diabetic deve-
lopment [4]. Fontvieille and other researchers suggested
that the increased 24-h sedentary energy expenditure
may play a role in the weight loss that is often observed
in Type 2 diabetic subjects in addition to the energy loss
from glycosuria [5]. Similar findings have been reported
recently in severely obese diabetic patients [6]. The re-
searchers suggested a new predictive equation for calcu-
lation of resting metabolic rate using gender, age, height,
weight and diabetes mellitus as variables [6]. In an ear-
lier study the race had been suggested as a variable as
well [7]. The inconsistent results and the different va-
riables suggested in these studies indicate that estima-
tion of resting metabolic rate in obese diabetic patients
using predictive equations may be misleading and re-
quires further investigations, especially in the tropics.Table 2 Oxygen consumption (VO2), carbon dioxide producti
diabetic and non-diabetic participants
VO2
Parameter Diabetic Non-diabetic Diabeti
N = 40 N = 40 N = 40
Minimum 153.0 143.0 155.0
Maximum 311.0 261.0 309.0
Mean 209.9 192.4 191.4
SD 42.7 28.1 35.0
CI 196.2-223.5 183.4-201.4 180.2-20
P value 0.034 0.050Results of a survey published in the past showed that
basal metabolic rate values of people in the tropics ap-
pear to be lower than values estimated with WHO pre-
dictive equations [8]. On the other hand; there is paucity
of data regarding relation of resting energy expenditure
to glycaemic control in obese diabetic patients. This
study was conducted to evaluate resting metabolic rate
among these patients and to assess its relation to labo-
ratory indicators of glycaemic control.
Methods
This is a case control study conducted in Jabir Abu-Eliz
centre in Khartoum- Sudan, in the period from January
to August 2012. A random sample of 40 obese diabetic
patients (cases) was selected from 190 patients attended
for follow up during that period. A sample of 40 obese
non-diabetic subjects (controls) was selected from the
co-patients. Inclusion criteria for both groups were age
35 to 50 years old, body mass index ≥ 30 kg/m2, non-
smoker, normotensive, afebrile and with no symptoms
or signs of acute or chronic infection. Cases were known
diabetics for at least one year, either on diet control
(27 patients) or stopped taking their anti-diabetic me-
dications for at least two days before presentation
(13 patients), whereas controls were non-diabetics. Both
groups were matched according to age, sex, height,
weight, physical activity, socioeconomic status and area
of residence. An anonymous interviewer-based question-
naire, requesting information about daily exercise and
present health status was applied to each participant.
Clinical examination was carried out to exclude signs of
acute or chronic medical abnormalities. Height and
weight of each participant was measured using stan-
dardized height and weight scales. Body mass index
(BMI) was calculated as weight (in kilograms)/height
(in meters2). Five micro litre of blood was taken for
Haemoglobin A1c measurement using the “NycoCard
Haemoglobin A1c test” (Axis -Shield/ Norway); with a
measuring range of 4-15% HbA1c. Fasting blood sugar
was measured using one touch® glucometer (LifeScanon (VCO2) and respiratory exchange ratio (RER) among
VCO2 RER
c Non-diabetic Diabetic Non-diabetic





2.6 171.1-185.5 0.88-0.98 0.90-0.97
0.868




n = 40 n = 40
Minimum 1155.6 1057.3
Maximum 2238.8 1787.3
Mean ± SD 1480.7 ± 274.2 1362.4 ± 184.8
CI 1393.0-1568.4 1303.3-1421.5
P value 0.027
Table 5 Resting metabolic rate (RMR) in relation to
fasting blood sugar
Fasting blood sugar
Parameter (< 126 mg/dL) (≥ 126 mg/dL)
n = 50 n = 30
Minimum 954.7 1050.6
Maximum 2824.6 2926.4
Mean ± SD 1358.6 ± 330.8 1407 ± 403.5
CI 1264.5-1452.6 1256.4-1557.8
P value 0.561
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Castle Hill Australia) data acquisition systems, com-
prising hardware and software, were used with bio amp-
lifier, thermistor, spirometer, gas analyzer, gas mains
chamber and a computer windows 7 program to record
and analyze physiological signals from participants. They
allowed measurement of oxygen consumption (VO2),
carbon dioxide production (VCO2), respiratory ventila-
tion (VE) and respiratory exchange ratio (RER). All par-
ticipants were fasting overnight. They were allowed to
rest in a thermally neutral room for 30 minutes before
measurements. Each test took less than 30 minutes, with
at least 5 minutes steady state. The steady state was de-
fined as minimal variation (< 10%) in VO2, VCO2, VE
and RER. Resting metabolic rate was calculated using
the Weir equation as follows [1,2]: RMR (kcal) = [(VO2)
(3.941) + (VCO2)(1.11)] 1440 min.
The research conforms to the ethical principles of
medical research developed by the World Medical Asso-
ciation Declaration of Helsinki [9]. Ethical clearance was
given by the Research Committee (Faculty of Medicine/
University of Al-Neelain). Approval was obtained from
the Ministry of Health. Written consents were obtained
from each participant before entry into the study. All
data obtained with questionnaire and biochemical ana-
lysis were analyzed using the Statistical Package for the
Social Sciences (SPSS) version 19. The chi square test
was used to test distribution of categorical variables. The
differences between test and control groups wereTable 4 Resting metabolic rate (RMR) in relation to
hemoglobin A1c
RMR/day
Parameter HbA1c <6.5% HbA1c ≥6.5%
n = 46 n = 34
Minimum 1057.3 1155.6
Maximum 1898.5 2238.8
Mean ± SD 1363.4 ± 195.4 1500.1 ± 273.1
CI 1305.4-1421.5 1404.9-1595.4
P value 0.016assessed with the student’s t test. Statistical significance
was accepted when P value is ≤ 0.05.
Results
Table 1 describes characteristics of cases (n = 40) and
controls (n = 40) in the study group. Male: Female ratio
was 1:1.5 in both groups. Statistical analysis showed
insignificant difference between the two groups in age
(P = 0.564), height (P = 0.094), weight (P = 0.486), body
mass index (P = 0.328) and surface area (P = 0.078).
Table 2 shows that VO2 (mean ± SD) ml/min was sig-
nificantly higher among cases (209.9 ± 42.7) compared to
the control group (192.4 ± 28.1), (P = 0.034). Similarly,
VCO2 (mean ± SD) ml/min was higher among cases
(191.4 ± 35.0) than controls (178.3 ± 22.5), (P = 0.05);
whereas the mean respiratory exchange ratio (RER) is
almost equal in the two groups (0.93 ± 0.16 and 0.93 ±
0.11 respectively). Table 3 shows higher resting meta-
bolic rate “RMR” (mean ± SD) among cases (1480.7 ±
274.2; CI = 1393.0-1568.4) than controls (1362.4 ± 184.8;
CI = 1303.3-1421.5), (P = 0.027). RMR was significantly
higher among participants with abnormal glycated
haemoglobin than those with normal glycated haemo-
globin (P = 0.016; Table 4). Insignificant difference was
found between those with normal and those with abnor-
mal fasting blood sugar (P = 0.561; Table 5).
Discussion
Measurement of energy expenditure is an important
element in the estimation of energy requirements in
man. In addition to its importance in scientific research,
it is becoming an essential tool in maintenance of a
healthy body weight. Obese subjects, especially those
with type II diabetes mellitus, may need special consi-
deration because insulin resistance in these individuals is
associated with abnormal metabolic reactions. In this
study, a significant difference in RMR was found bet-
ween obese diabetic and obese non-diabetic subjects.
The difference was associated with higher rate of oxygen
consumption and carbon dioxide production that caused
rise in resting metabolic rate among the diabetic
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suggested to explain similar findings. One of the proposed
mechanisms was an increase in gluconeogenesis [10]. It
has been suggested that the increased free fatty acid con-
centration in diabetic patients contributes to the excessive
rates of gluconeogenesis and therefore to increased rate
energy expenditure in these patients. Indian patients with
type II diabetes mellitus showed higher rate of energy ex-
penditure correlating with increased endogenous release
of glucose from the liver [5]. In support with this mecha-
nism, a reduction in resting energy expenditure was
reported, following improvement in glycaemic control
[11]. Similarly in this study, we found lower resting meta-
bolic rates in patients with well controlled diabetes
mellitus, as indicated with normal glycated haemoglobin,
compared to those with poor control. However, insig-
nificant relation with fasting blood sugar was also found.
This indicates that, glycaemic control has long term rather
than short term effect on resting energy expenditure.
Other proposed mechanisms include abnormal protein
metabolism [12], increased sympathetic activity [13] and
hyperglucagonaemia [14]. Diabetic patients in poor con-
trol show an increased protein turnover, requiring an
increased protein synthesis, which is associated with
higher rate of energy release [12,15]. There is an evidence
that sympathetic nervous system activity is increased in
hyperinsulinemic individuals with type 2 diabetes com-
pared with non-diabetic control subjects [13]. On the
other hand, it has been found that lowering glucagon
levels during insulin deprivation decreased the resting
metabolic rate by more than 7% [14]. These findings indi-
cate that high levels of glucagon, which is a known finding
in diabetes mellitus, may be responsible for the rise in en-
ergy expenditure among diabetic patients [15]. Recently it
has been suggested that glucagon might be responsible for
both the hyperglycaemia and the occasional hypogly-
caemia seen in diabetic patients [16].
It is worth noting that, variation in resting metabolic
rate between individuals of the same ethnicity is not un-
common. In a previous study, it was reported that basal
metabolic rate values in a population varied from as low
as 1027 kcal/day to as high as 2499 kcal; with a mean of
1500 kcal/day [17]. Similarly in our study, resting meta-
bolic rate varied within diabetic patients from 1155.6
to 2238.8 kcal/day with a mean of 1480.7 kcal/day,
and within the non-diabetic subjects from 1057.3 to
1787.3 kcal/day with a mean of 1362.4 kcal/day. The
inter-individual differences in RMR within each group
may be explained by variation in age, sex, muscle bulk
and level of circulating hormones. It is worth noting
that, variation in rate of energy release within the same
subject “intra-individual variation” may contribute to
this finding. In one study, intra-individual variation was
found to be within a range of 5% [18].One of the major limitations in this study is matching
cases and controls. Although our objective measure-
ments showed insignificant difference between the two
groups in weight and height, we can’t exclude recall bias
in other factors like age, residence and physical activity.
In addition, we can’t confirm that one third of our dia-
betic participants missed their anti-diabetic medications
two days before the study. However, this appears to be a
common practice [19]. In one study, more than 50% of
patients with insulin dependent diabetes mellitus missed
their insulin dose [19].
Conclusion
This study showed that resting metabolic rate is signifi-
cantly higher among obese diabetic patients compared
to obese non-diabetics. High resting metabolic rate has a
significant relation with abnormal level of glycated hae-
moglobin but not with high fasting blood sugar, indica-
ting that poor glycaemic control has a long term, rather
than a short term effect on resting metabolic rate.
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